To Support Emergency Efforts, Verizon Wireless Launches Broadband Network in Iowa City

IOWA CITY, Iowa, June 15 /PRNewswire/ -- Verizon Wireless announced the rollout of its high-speed wireless network in Iowa City to support communications services for the University of Iowa and other emergency personnel during the severe flooding in the area.

"Our network team has worked around the clock to upgrade this service ahead of schedule because of the need for mobile communications services in Iowa City," said Nancy B. Clark, president-Great Plains Region, Verizon Wireless. "In addition, we were able to activate a new cell site near Kinnick Stadium, also ahead of schedule, to further support wireless communications."

Verizon Wireless has donated phones and USB modems to emergency personnel and relief organizations in Iowa. The company's BroadbandAccess service is being utilized with laptop computers and USB modems to access the Internet -- the high-speed network was already deployed in Cedar Rapids and other areas of Iowa.

The company is monitoring network performance and has added capacity to cell sites throughout the flood damaged areas of Iowa. All Verizon Wireless Communications Stores are open to assist customers.

About Verizon Wireless

Verizon Wireless operates the nation's most reliable wireless voice and data network, serving 67.2 million customers. Headquartered in Basking Ridge, N.J., with 69,000 employees nationwide, Verizon Wireless is a joint venture of Verizon Communications and Vodafone (NYSE and LSE: VOD). For more information, go to: http://www.verizonwireless.com/. To preview and request broadcast- quality video footage and high-resolution stills of Verizon Wireless operations, log on to the Verizon Wireless Multimedia Library at http://www.verizonwireless.com/multimedia.

Verizon Wireless

CONTACT: Karen Smith of Verizon Wireless, +1-612-590-3511,
Karen.Smith@VerizonWireless.com, or Debbie Hilt, for Verizon Wireless
+1-402-350-5222, Debbie@AlbersCommunications.com

Web site: http://www.verizonwireless.com/

A Clearer View of High Definition: Siemens Turns the Spotlight on Pioneers of HD-PET With In-Booth Exhibit at SNM 2008

NEW ORLEANS, June 15 /PRNewswire-FirstCall/ -- Siemens Healthcare (http://www.siemens.com/healthcare) honors the early adapters of its innovative high-definition positron emission tomography (HD-PET) technology at the 2008 Society of Nuclear Medicine (SNM) Scientific Sessions in New Orleans, June 14-18. The Siemens booth (#731) will feature experiences from early adopters as testament to the power of this new technology, and highlighting how HD-PET is enabling improved patient care all over the world.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

Siemens' HD-PET is the world's first and only high-definition PET technology to offer consistently sharper and clearly defined images across the entire field of view. The clarity achieved by HD-PET is the result of a unique and proprietary technology that optimizes the elements of image uniformity, resolution and contrast -- that together change the whole picture.

"HD-PET is a real technological advancement for challenging imaging situations, in particular, for small lesions and breath-dependent lesions," said Professor Dr. W. Mohnike, of the Diagnostic Therapy Center in Berlin.

Historically with PET imaging, intrinsic image quality has been known to degrade with increasing distance from the center of the detector, but with HD-PET, there is uniform resolution across the entire field of view. The improved resolution enables physicians to clearly visualize small lesions from the center to the edges of the field of view.

Professor Mike Fulham of Royal Prince Alfred Hospital in Sydney, Australia, agrees. "Our HD-PET studies are a major improvement in study quality; they are clearer, provide better delineation and detection of small foci of disease; they offer improved confidence in diagnosis and diagnostic accuracy, which improves patient care," he said. HD-PET could potentially improve diagnosis and staging of disease and, hence, clinical outcomes for patients.

HD-PET, in combination with TrueV extended field of view, maximizes patient throughput and increases overall utilization.

"Our Biograph 64 has enabled our hospital to image 49 patients in a single day, and our monthly record is 764 patients," said Xu Zhensheng, director of Shanghai Fudan University affiliated Huashan Hospital PET center in Shanghai, China,

An entire section of the Siemens booth is dedicated to showcasing even more facilities using HD-PET and changing the management of their patients' care.

About Siemens Healthcare

Siemens Healthcare is one of the world's largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first fully integrated diagnostics company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care -- from prevention and early detection, to diagnosis, therapy and care. Additionally, Siemens is the global market leader in innovative hearing instruments. The company employs more than 49,000 people worldwide and operates in 130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare reported sales of euro 9.85 billion, orders of euro 10.27 billion, and group profit of euro 1.32 billion. Further information can be found by visiting http://www.siemens.com/healthcare.

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk, photodesk@prnewswire.com Siemens Healthcare

CONTACT: Tom Schaffner of Siemens Healthcare, +1-610-448-1477,
thomas.schaffner@siemens.com

Web site: http://www.siemens.com/healthcare

Siemens Asks: What's Your SPECT'S IQ?Intelligent New Symbia Feature Offers Maximum Speed and Utility in SPECT Scanning*

NEW ORLEANS, June 15 /PRNewswire-FirstCall/ -- Taking innovation and efficiency to the next level, Siemens Healthcare (http://www.siemens.com/healthcare) announces the next big thing in SPECT imaging: "intelligence." At the 2008 Society of Nuclear Medicine Annual Meeting, June 14-18, in New Orleans, IQ- SPECT (Works in Progress) takes center stage as Siemens newest Symbia(R) feature that enables a comprehensive cardiac evaluation including perfusion, attenuation correction and calcium scoring in just five minutes**.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

"This exciting new Symbia feature is really all about added value and optimization. IQ-SPECT improves the performance of the Symbia by allowing it to become organ specific and provide complete cardiac evaluations with an extremely quick turnaround time," says Michael Reitermann, chief executive officer, Molecular Imaging, Siemens Medical Solutions USA, Inc. "And because of its speed and versatility, IQ-SPECT offers enhanced cardiac image quality and thus offers physicians more confident diagnostic ability because of decreased patient movement. We expect this new capability to provide organ specific, cardiac imaging on general purpose systems, as it could potentially expand to other organs as well."

IQ-SPECT technology is achieved with SMARTZOOM, a specially designed "smart" collimator that magnifies the heart while imaging the rest of the torso under traditional conditions. Typically, cardiac SPECT data is obtained through keeping the detectors positioned at 90 degrees and as close to the body as possible, utilizing mechanically centered detector rotation, where organ specific magnification cannot be achieved. The flexible mechanics of the Symbia S and T gantries allow an organ centric detector rotation that can zero-in on the organ of interest; in this case, the heart. Combining this organ centric orbit acquisition technique, fast, 3D iterative reconstruction that is optimized for more confident diagnoses, and improved patient comfort from a quicker scan, IQ-SPECT will set the standard for image quality, speed, productivity and throughput.

IQ-SPECT will be available for all new Symbia S and T systems, and is field upgradeable for any existing Symbia S or T systems that are already widely available in leading hospitals and imaging centers across the globe. The new SMARTZOOM feature is seamlessly integrated into the current Symbia workflows and automation features, giving users access to the most flexible and versatile system available today. From a user perspective, IQ-SPECT is fully automated and can therefore accommodate more patients per day and meet a variety of patient needs. For example, pediatric patients can benefit from a lower injected dose in regular acquisition time, or from less motion and more comfort with a regular dose and quicker acquisition time. A quicker scan allows for less patient movement and lowers the probability of retakes.

Using traditional SPECT systems, cardiac perfusion studies average about 15 to 20 minutes, limiting the amount of patients per day. With an "intelligent" Symbia IQ-SPECT imager, more patients can be scanned per day in much less time; as little as four minutes per patient for a full cardiac work- up.

Raising the bar even higher in well-established myocardial perfusion SPECT imaging evaluations is possible with hybrid Symbia SPECT-CT and IQ-SPECT. The addition of calcium scoring, extracted from a quick low-dose spiral CT scan that is also used to obtain attenuation correction information, is becoming a critical element in the cardiac work-up to screen patients for coronary artery disease (CAD). It can improve the risk stratification of patients who are at intermediate to high risk. Calcium scoring is an independent indicator of prognosis in CAD and in combination with SPECT, does improve diagnostic confidence.

Adding the 30-second CT to the SPECT study can not only illustrate any ischemia present in the patient, but also can assess the buildup of calcium in the coronary arteries. Because many heart attacks occur in patients without obvious signs or risk factors, calcium scoring can definitively screen for and detect CAD. The addition of IQ-SPECT to SPECT-CT studies may lead to new risk stratification algorithms and work-ups for patients with suspected CAD.

About Siemens Healthcare

Siemens Healthcare is one of the world's largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first fully integrated diagnostics company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care - from prevention and early detection, to diagnosis, therapy and care. Additionally, Siemens is the global market leader in innovative hearing instruments. The company employs more than 49,000 people worldwide and operates in 130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare reported sales of euro 9.85 billion, orders of euro 10.27 billion, and group profit of euro 1.32 billion. Further information can be found by visiting http://www.siemens.com/healthcare.

* Works In Progress. The information about the product is preliminary. The product is under development and is not commercially available in the United States, and its future availability cannot be ensured. ** New product feature based on preliminary internal data. Actual performance characteristics have not been established.

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk, photodesk@prnewswire.com Siemens Healthcare

CONTACT: Tom Schaffner of Siemens Healthcare, +1-610-448-1477,
thomas.schaffner@siemens.com

Web site: http://www.siemens.com/healthcare

Elbit Systems and the Israel Institute of Technology (Technion) to Establish New Vision Systems Research CentreElbit Systems to offer Technion researchers an advanced laboratory, research grants and guidance in unique research fields

HAIFA, Israel, June 15 /PRNewswire-FirstCall/ -- Elbit Systems Ltd. and the Haifa-based Israel Institute of Technology (the "Technion") signed a joint research agreement in the field of vision systems. According to the agreement, Elbit Systems will award research grants during the next five years, to selected Technion researchers of the Electrical Engineering Department. These researchers will support their research using Elbit Systems' advanced Eye Tracking laboratory.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080408/300441 )

Elbit Systems recently published a call for research in vision and computer aided vision fields, directed at students and researchers from the Electrical Engineering Department of the Technion. Elbit Systems has so far received numerous research requests from both undergraduate and graduate students. The Grant Committee, which includes Elbit Systems' R&D representatives and a Technion observer, will soon determine which of the research requests will be granted. The Committee will continue to follow additional research fields suitable for the award of research grants in the coming years.

Researchers in the eye tracking field will examine, among other aspects, the human eye's capability to track objects in space, and qualify and categorize the objects perceived (3D movement, etc.). The vision researches' findings are expected to contribute to the improvement of data fusion capabilities in determining targeted objects' outlines, efficient automatic calibration in case of overlapping cameras' fields of vision, picture reconstruction and more.

"The new program we are launching and Elbit Systems' annual donation to the research in the vision systems field reflect the fruitful, reciprocal cooperation between the Technion and industry," said Yitzhak Apeloig, the Technion President. "I trust that both our students and Elbit Systems will benefit from this cooperation and soon reap its benefits. On behalf of the Technion and the

Faculty of Electrical Engineering Department, the Technion's flagship and largest department, I express my gratitude to Elbit Systems, the flagship of the Israeli industry."

"Elbit Systems is proud to be an active partner in advancing the research activity performed at the Technion, one of the most technologically advanced research institutions in the world," said Joseph Ackerman, Elbit Systems' President and CEO. "We see our constant investment in R&D a central ingredient in Elbit Systems' success so far, and vital for the maintenance of our leadership in the highly competitive global defense industry. Over the generations, many Technion graduates have joined Elbit Systems. We take pleasure in our ability to contribute and offer more Technion students the opportunity to research the fascinating field of vision systems and particularly eye tracking during their studies."

Elbit Systems is a world leader in vision systems, offering its cutting edge technology in diverse fields, such as advanced helmet mounted systems for combat aircraft, providing pilots with critical flight and mission information which is projected on-line into the pilots' helmets, without the need to turn or lower their gaze. The electromagnetic position tracking technology enables accurate detection of the pilot's head position and field of vision.

About Elbit Systems

Elbit Systems Ltd. is an international defense electronics company engaged in a wide range of defense-related programs throughout the world. The Company, which includes Elbit Systems and its subsidiaries, operates in the areas of aerospace, land and naval systems, command, control, communications, computers, intelligence surveillance and reconnaissance ("C4ISR"), unmanned air vehicle (UAV) systems, advanced electro-optics, electro-optic space systems, EW suites, airborne warning systems, ELINT systems, data links and military communications systems and radios. The Company also focuses on the upgrading of existing military platforms and developing new technologies for defense, homeland security and commercial aviation applications.

Contacts: Company Contact: IR Contact: Joseph Gaspar, Executive VP & CFO Ehud Helft / Kenny Green Dalia Rosen, Head of Corporate Communications Elbit Systems Ltd G.K. Investor Relations Tel: +972-4-8316663 Tel: 1-646-201-9246 Fax: +972-4-8316944 Fax: +972-3-607-4711 E-mail: gspr@elbit.co.il E-mail: info@gkir.com daliarosen@elbit.co.il

This press release contains forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended) regarding Elbit Systems Ltd. and/or its subsidiaries (collectively the Company), to the extent such statements do not relate to historical or current fact. Forward Looking Statements are based on management's expectations, estimates, projections and assumptions. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results, performance and trends may differ materially from these forward-looking statements due to a variety of factors, including, without limitation: scope and length of customer contracts; governmental regulations and approvals; changes in governmental budgeting priorities; general market, political and economic conditions in the countries in which the Company operates or sells, including Israel and the United States among others; differences in anticipated and actual program performance, including the ability to perform under long-term fixed-price contracts; and the outcome of legal and/or regulatory proceedings. The factors listed above are not all-inclusive, and further information is contained in Elbit Systems Ltd.'s latest annual report on Form 20-F, which is on file with the U.S. Securities and Exchange Commission. All forward-looking statements speak only as of the date of this release. The Company does not undertake to update its forward- looking statements.

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20080408/300441
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk, photodesk@prnewswire.com Elbit Systems Ltd.

CONTACT: Joseph Gaspar, Executive VP & CFO, gspr@elbit.co.il, or Dalia
Rosen, Head of Corporate Communications, daliarosen@elbit.co.il, both of Elbit
Systems Ltd, +972-4-8316663, or fax, +972-4-8316944; IR Contact: Ehud Helft or
Kenny Green, both of G.K. Investor Relations, +1-646-201-9246, or fax,
+972-3-607-4711, info@gkir.com

page 1    

News archive of November 2009
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30